ClinicalTrials.Veeva

Menu

Chronic Obstructive Pulmonary Diseases and Proprioceptive Neuromuscular Facilitation

M

Medipol Health Group

Status

Completed

Conditions

Chronic Obstructive Pulmonary Disease

Treatments

Diagnostic Test: MIP/MEP

Study type

Interventional

Funder types

Other

Identifiers

NCT05723302
IstanbulMUH_1999

Details and patient eligibility

About

To investigate the effects of resistant proprioceptive neuromuscular facilitation exercises on physical fitness, respiratory muscle strength, walking distance and quality of life in chronic obstructive pulmonary patients.

Full description

The study was carried out between January 2017 and January 2019, with patients followed up with the diagnosis of COPD in Çanakkale Mehmet Akif Ersoy State Hospital and Çanakkale Onsekiz Mart University Medical Faculty Hospital, Department of Chest Diseases. It was approved by Istanbul Medipol University Non-Interventional Clinical Research Ethics Committee (Date: 30.12.2016, Decision No. 573) and was done in accordance with the Declaration of Helsinki. All participants were informed about the purpose of the study, the total duration of treatment and the applications to be made, and a consent form was signed. The study was conducted as a prospective and randomized controlled study, and inclusion and exclusion criteria were determined.

Thirty-five patients diagnosed with COPD were referred to the study, four patients were excluded because they did not meet the inclusion criteria, and the study was conducted with a total of 31 participants.

The 31 patients included in the study were randomized after their initial evaluation and divided into two groups as experimental and control groups. Patients meeting the inclusion criteria were divided into 2 groups. Randomized by ordering by date of application.

Enrollment

31 patients

Sex

All

Ages

38 to 67 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • To be diagnosed with stage 1, stage 2 and stage 3 COPD according to GOLD (Global Initiative for Obstructive Lung Diseases) criteria
  • Having FEV1/FVC <70% according to pulmonary function test
  • Being clinically stable
  • Being over 18 years old
  • Volunteer to participate in the program

Exclusion criteria

  • Having a COPD exacerbation in the last 8 weeks
  • To have participated in a regular exercise training program in the last 1 year
  • Having a musculoskeletal disease and neuromuscular disease that may prevent exercise
  • Inability to cooperate for pulmonary function test and respiratory muscle strength measurement
  • Being on long-term oxygen therapy

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

31 participants in 2 patient groups

Maximal Inspiratory Pressure
Experimental group
Description:
MIP Maximal Inspiratory Pressure
Treatment:
Diagnostic Test: MIP/MEP
Maximal Expiratory Pressure
Experimental group
Description:
MEP Maximal Expiratory Pressure
Treatment:
Diagnostic Test: MIP/MEP

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems